Improving brain age prediction models: incorporation of amyloid status in Alzheimer's disease

Neurobiol Aging. 2020 Mar:87:44-48. doi: 10.1016/j.neurobiolaging.2019.11.005. Epub 2019 Nov 14.

Abstract

Brain age prediction is a machine learning method that estimates an individual's chronological age from their neuroimaging scans. Brain age indicates whether an individual's brain appears "older" than age-matched healthy peers, suggesting that they may have experienced a higher cumulative exposure to brain insults or were more impacted by those pathological insults. However, contemporary brain age models include older participants with amyloid pathology in their training sets and thus may be confounded when studying Alzheimer's disease (AD). We showed that amyloid status is a critical feature for brain age prediction models. We trained a model on T1-weighted MRI images participants without amyloid pathology. MRI data were processed to estimate gray matter density voxel-wise, which were then used to predict chronological age. Our model performed accurately comparable to previous models. Notably, we demonstrated more significant differences between AD diagnostic groups than other models. In addition, our model was able to delineate significant differences in brain age relative to chronological age between cognitively normal individuals with and without amyloid. Incorporation of amyloid status in brain age prediction models ultimately improves the utility of brain age as a biomarker for AD.

Keywords: Alzheimer's disease; Amyloid; Brain aging; Brain reserve; Cognitive reserve; Resilience.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aging*
  • Alzheimer Disease / diagnostic imaging
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / psychology
  • Amyloid beta-Peptides / metabolism*
  • Brain / diagnostic imaging
  • Brain / metabolism*
  • Cognitive Reserve
  • Diffusion Magnetic Resonance Imaging
  • Female
  • Forecasting
  • Humans
  • Machine Learning
  • Male
  • Middle Aged
  • Neuroimaging

Substances

  • Amyloid beta-Peptides